Oral Contraceptives and the Risk of Cardiovascular Disease

被引:1
作者
Luo J. [1 ]
Margolis K.L. [2 ]
机构
[1] Department of Community Medicine, West Virginia University, Morgantown, WV, 26506-9190
[2] HealthPartners Research Foundation, Minneapolis, MN, 55440-1524, PO Box 1524
关键词
Myocardial infarction; Oral contraceptives; Stroke; Venous thromboembolism;
D O I
10.1007/s12170-010-0095-7
中图分类号
学科分类号
摘要
Over the years, the estrogen dose in combined oral contraceptives has been progressively reduced to decrease the risk of thrombosis; however, the cardiovascular safety of widely used oral contraceptives is still a concern. Low-dose oral contraceptives, especially those containing certain third-generation progestins, have been found to increase the risk of venous thrombosis. Low-dose oral contraceptive use has not been clearly shown to increase the risk of arterial vascular disease. The risk of arterial and venous thrombosis in young healthy women taking low-dose oral contraceptives is outweighed by the risks of unintended pregnancy. Women with cardiovascular risk factors, particularly smoking, must weigh the risk of thrombotic events against the convenience and efficacy of alternative methods for preventing pregnancy. As oral contraceptives are increasingly used in the later reproductive years, further research is needed to define the risks in older women, for whom the prevalence of risk factors and the incidence of cardiovascular disease are higher. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码:222 / 228
页数:6
相关论文
共 50 条
  • [21] Combined oral contraceptives and the risk of myocardial infarction
    Keeling, D
    ANNALS OF MEDICINE, 2003, 35 (06) : 413 - 418
  • [22] Cardiovascular risks of combined oral contraceptives - beyond the French controversy
    Gronier-Gouvernel, H.
    Robin, G.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2014, 42 (03): : 174 - 181
  • [23] AN EPIDEMIOLOGIC SURVEY OF CARDIOVASCULAR-DISEASE IN WOMEN TAKING ORAL-CONTRACEPTIVES
    THOROGOOD, M
    VESSEY, MP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) : 274 - 281
  • [24] Cardiovascular Risks of Hormonal Contraceptives
    Petitti D.B.
    Current Cardiovascular Risk Reports, 2013, 7 (3) : 190 - 195
  • [25] Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel
    Jick, Susan S.
    Kaye, James A.
    Russmann, Stefan
    Jick, Hershel
    CONTRACEPTION, 2006, 73 (06) : 566 - 570
  • [26] Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis
    Martinelli, I
    Battaglioli, T
    Mannucci, PM
    PHARMACOGENETICS, 2003, 13 (10): : 589 - 594
  • [27] Oral hormonal contraceptives and cardiovascular risks in females
    Bhullar, Sukhwinder K.
    Rabinovich-Nikitin, Inna
    Kirshenbaum, Lorrie A.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2024, 102 (10) : 572 - 584
  • [28] Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study - Oral contraceptives and the risk of ischemic stroke
    Kemmeren, JM
    Tanis, BC
    van den Bosch, MAAJ
    Bollen, ELEM
    Helmerhorst, FM
    van der Graaf, Y
    Rosendaal, FR
    Algra, A
    STROKE, 2002, 33 (05) : 1202 - 1208
  • [30] APC resistance and third-generation oral contraceptives - Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease
    Gris, JC
    Jamin, C
    Benifla, JL
    Quere, I
    Madelenat, P
    Mares, P
    HUMAN REPRODUCTION, 2001, 16 (01) : 3 - 8